Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Income from Continuing Operations (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Income from Continuing Operations data on record, last reported at 164000000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations changed N/A year-over-year to 164000000.0; the TTM value through Dec 2025 reached 368000000.0, changed N/A, while the annual FY2025 figure was 353000000.0, 24.73% down from the prior year.
  • Income from Continuing Operations reached 164000000.0 in Q4 2025 per RCUS's latest filing, down from 112000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 279538000.0 in Q4 2021 and bottomed at 164000000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 58022058.82, with a median of 75000000.0 recorded in 2023.
  • The widest YoY moves for Income from Continuing Operations: up 637.62% in 2021, down 4379.64% in 2021.
  • A 5-year view of Income from Continuing Operations shows it stood at 279538000.0 in 2021, then tumbled by 123.97% to 66996000.0 in 2022, then dropped by 20.9% to 81000000.0 in 2023, then dropped by 13.58% to 92000000.0 in 2024, then crashed by 78.26% to 164000000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 164000000.0 in Q4 2025, 112000000.0 in Q1 2025, and 92000000.0 in Q3 2024.